Equillium (EQ) Current Taxes (2017 - 2025)

Equillium (EQ) reported Current Taxes of $17000.0 for Q3 2025, little changed quarter-over-quarter from $17000.0 in Q2 2025.

Equillium (EQ) Current Taxes (2017 - 2025) Analysis & Trends

Equillium (EQ) has 4 years of Current Taxes data on file, last reported at $17000.0 in Q3 2025.

Current Taxes for Q3 2025 came in at $17000.0, changed N/A year-over-year; the trailing twelve-month figure through Sep 2025 was $17000.0 (changed N/A YoY), and the FY2024 annual result was $365000.0, changed N/A from the prior year.
Current Taxes steadied at $17000.0 in Q3 2025 per EQ's latest filing, from $17000.0 in the prior quarter.
Over five years, Current Taxes peaked at $564000.0 in Q3 2023 and troughed at $17000.0 in Q2 2025.
A 3-year average of $265600.0 and a median of $365000.0 in 2024 frame the typical range for Current Taxes.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Alterity Therapeutics	925,601.88 Bn	925,601.85 Bn	-	10,460.56
2	Belite Bio	58,560.00 Bn	58,560.00 Bn	-	-
3	Quantum Biopharma	17,284.41 Bn	17,284.40 Bn	-	-
4	Legend Biotech	2,809.00 Bn	2,808.71 Bn	242.10 Mn	19.20 Mn
5	Evaxion A	1,334.43 Bn	1,334.42 Bn	-	-
6	Akari Therapeutics	1,312.27 Bn	1,312.26 Bn	-	-
7	Psyence Biomedical	212.16 Bn	212.16 Bn	-	-
8	Vertex Pharmaceuticals	114.83 Bn	107.58 Bn	2.59 Bn	-
9	Abivax	91.96 Bn	91.96 Bn	-	-
10	Equillium	293.17 Mn	232.78 Mn	-	-

Download Data